Key facts
- This page summarizes Robert Andrade's Form 4 filing for FENNEC PHARMACEUTICALS INC. (FENC).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 30 Jun 2023, 16:21.
Robert Andrade - 28 Jun 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)
- Reporting relationship
- CHIEF FINANCIAL OFFICER
- Issuer ticker
- FENC
- Reported as of
- 28 Jun 2023
- Net transaction value
- -$223,325
- SEC form
- 4
- Accepted by SEC
- 30 Jun 2023, 16:21:11 UTC
- Prior SEC filing
- 03 Apr 2023
- Next SEC filing
- 05 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Andrade
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Andrade filed Form 4 for FENNEC PHARMACEUTICALS INC. (FENC) on 30 Jun 2023.
Change
- Previous filing in this sequence was filed on 03 Apr 2023.
- Current net transaction value: -$223,325.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FENC
transaction
Common shares
Sale
- Transaction value
- $89,900
- Shares
- -10,000
- Change %
- -6.7%
- Price
- $8.99
- Shares after
- 139,721
- Date
- 28 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
FENC
transaction
Common shares
Sale
- Transaction value
- $67,275
- Shares
- -7,500
- Change %
- -5.4%
- Price
- $8.97
- Shares after
- 132,221
- Date
- 29 Jun 2023
- Ownership
- Direct
- Footnotes
- F2
FENC
transaction
Common shares
Sale
- Transaction value
- $66,150
- Shares
- -7,500
- Change %
- -5.7%
- Price
- $8.82
- Shares after
- 124,721
- Date
- 30 Jun 2023
- Ownership
- Direct
- Footnotes
- F3
FENC
transaction
Common shares
Options Exercise
- Transaction value
- $61,250
- Shares
- +25,000
- Change %
- +20%
- Price
- $2.45
- Shares after
- 149,721
- Date
- 30 Jun 2023
- Ownership
- Direct
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FENC
transaction
Derivative
Common Shares
Options Exercise
- Transaction value
- $61,250
- Shares
- -25,000
- Change %
- -4%
- Price
- $2.45
- Shares after
- 605,000
- Date
- 30 Jun 2023
- Ownership
- Direct
- Underlying class
- Options
- Underlying amount
- 25,000
- Exercise price
- $2.45
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 5 footnotes
Footnote F1
Represents shares sold pursuant to a 10b5-1 plan on June 28, 2023.
Footnote F2
Represents shares sold pursuant to a 10b5-1 plan on June 29, 2023.
Footnote F3
Represents shares sold pursuant to a 10b5-1 plan on June 30, 2023.
Footnote F4
Shares aquired through the exercise of option contract with a strike price of $2.45 and an expiration date of July 5, 2026.
Footnote F5
Represents options granted on July 5, 2016, with a strike price of $2.45 and expiration date of July 5, 2026.